EMA Authorised: Fycompa (perampanel) — Eisai GmbH

View source ↗

Summary

The European Medicines Agency authorised Fycompa (perampanel) by Eisai GmbH for partial-onset seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Fycompa (perampanel)

Snippet

Status: Authorised. Therapeutic area: Epilepsies, Partial. MAH: Eisai GmbH. Decision date: 27/04/2023